These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 2741901)
21. A patient with methotrexate lung and granulomatous changes in the liver--or just sarcoidosis? van Deursen CT; Koudstaal J; Maesen FP Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):293-6. PubMed ID: 3410605 [TBL] [Abstract][Full Text] [Related]
22. [Liver damage due to cytostatic agents]. Tomík F; Dusek J; Vavrecka A; Horák I Bratisl Lek Listy; 1985 May; 83(5):521-9. PubMed ID: 4040792 [No Abstract] [Full Text] [Related]
23. Pulmonary and hepatic complications of methotrexate therapy of psoriasis. Filip DJ; Logue GL; Harle TS; Farrar WH JAMA; 1971 May; 216(5):881-2. PubMed ID: 5108291 [No Abstract] [Full Text] [Related]
26. Detection of hepatotoxicity associated with methotrexate therapy for psoriasis. O'Connor GT; Olmstead EM; Zug K; Baughman RD; Beck JR; Dunn JL; Seal P; Lewandowski JF Arch Dermatol; 1989 Sep; 125(9):1209-17. PubMed ID: 2774596 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis. Weinstein GD; Cox JW; Suringa DW; Millard MM; Kalser M; Frost P Arch Dermatol; 1970 Dec; 102(6):613-8. PubMed ID: 5501902 [No Abstract] [Full Text] [Related]
28. Liver biopsies in patients with rheumatoid arthritis receiving methotrexate: where are we going? Kremer JM J Rheumatol; 1992 Feb; 19(2):189-91. PubMed ID: 1629814 [No Abstract] [Full Text] [Related]
29. [Laboratory and oligobiopsy examination of the liver in patients with psoriasis treated with methotrexate (preliminary report)]. Ruszczak Z; Prószyńska-Kuczyńska W; Babiński S; Biernat S; Kulig A Przegl Dermatol; 1974; 61(6):803-7. PubMed ID: 4431967 [No Abstract] [Full Text] [Related]
30. Diffuse hepatic uptake of technetium-99m methylene diphosphonate in a patient receiving high dose methotrexate. Flynn BM; Treves ST J Nucl Med; 1987 Apr; 28(4):532-4. PubMed ID: 3572537 [TBL] [Abstract][Full Text] [Related]
31. Hepatotoxicity of methotrexate in the treatment of psoriasis. Roenigk HH; Bergfeld WF; St Jacques R; Owens FJ; Hawk WA Arch Dermatol; 1971 Mar; 103(3):250-61. PubMed ID: 5548272 [No Abstract] [Full Text] [Related]
32. [Local obliterative hepatic endophlebitis and hepatosclerosis as a consequence of the therapy of infantile leukosis]. Hill K; Jüngst BK Acta Hepatosplenol; 1969; 16(5):297-307. PubMed ID: 5358868 [No Abstract] [Full Text] [Related]
33. [Toxic liver disorders seen in liver biopsy]. Taki T; Kondo K; Sumie H; Kuwabara N; Takagi T Rinsho Byori; 1971 Aug; 19():Suppl:496. PubMed ID: 5168158 [No Abstract] [Full Text] [Related]
34. The aminopyrine breath test, an inadequate early indicator of methotrexate-induced liver disease in patients with psoriasis. Williams CN; McCauley D; Malatjalian DA; Turnbull GK; Ross JB Clin Invest Med; 1987 Mar; 10(2):54-8. PubMed ID: 3581546 [TBL] [Abstract][Full Text] [Related]
35. Use of methotrexate in psoriasis. Roenigk HH; Maibach HI; Weinstein GD Arch Dermatol; 1972 Mar; 105(3):363-5. PubMed ID: 5012144 [No Abstract] [Full Text] [Related]
36. Practice gaps. Methotrexate-induced liver toxicity: replacing the liver biopsy. Strober BE JAMA Dermatol; 2014 Aug; 150(8):862-3. PubMed ID: 24965863 [No Abstract] [Full Text] [Related]
37. Hazards of prolonged low-dose methotrexate therapy. Bender AS Va Med Mon (1918); 1970 Apr; 97(4):218-9. PubMed ID: 5317468 [No Abstract] [Full Text] [Related]
38. Ultrastructure of peliosis hepatis in a percutaneous biopsy. Ross RC; Kovacs K; Horvath E Pathol Eur; 1972; 7(3):273-82. PubMed ID: 4571538 [No Abstract] [Full Text] [Related]
39. Assessing the preferences of patients with psoriasis. A quantitative, utility approach. Zug KA; Littenberg B; Baughman RD; Kneeland T; Nease RF; Sumner W; O'Connor GT; Jones R; Morrison E; Cimis R Arch Dermatol; 1995 May; 131(5):561-8. PubMed ID: 7741543 [TBL] [Abstract][Full Text] [Related]